Merkzettel Warenkorb
Produktbild: Crohn's Disease and Ulcerative Colitis
- 10%

Crohn's Disease and Ulcerative Colitis From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach

10% sparen

172,99 € UVP 192,59 €

inkl. gesetzl. MwSt., Versandkostenfrei

Lieferung nach Hause

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

10.03.2017

Abbildungen

XX, 204 illus., 144 illus. in color., farbige Illustrationen, schwarz-weiss Illustrationen

Herausgeber

Daniel C. Baumgart

Verlag

Springer

Seitenzahl

695

Maße (L/B/H)

28,5/21,5/4,4 cm

Gewicht

1968 g

Auflage

Second Edition 2017

Sprache

Englisch

ISBN

978-3-319-33701-2

Beschreibung

Rezension

“This very complete book is an excellent resource on inflammatory bowel disease (IBD), discussing in detail all aspects of Crohn's disease and ulcerative colitis. … This book is written for a very broad audience, from physicians and scientists to all healthcare personnel, who deal with IBD patients. … All areas are covered in detail. Even though this is a large book, it is easy to read.” (Henrique Fernandez, Doody’s Book Reviews, September, 2017) 

Portrait

Daniel C. Baumgart, MD

Inflammatory Bowel Disease Center

Department of Gastroenterology and Hepatology

Charité  Medical Center--Virchow Hospital

Medical School of the Humboldt University of Berlin

Berlin, Germany

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

10.03.2017

Abbildungen

XX, 204 illus., 144 illus. in color., farbige Illustrationen, schwarz-weiss Illustrationen

Herausgeber

Daniel C. Baumgart

Verlag

Springer

Seitenzahl

695

Maße (L/B/H)

28,5/21,5/4,4 cm

Gewicht

1968 g

Auflage

Second Edition 2017

Sprache

Englisch

ISBN

978-3-319-33701-2

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Crohn's Disease and Ulcerative Colitis
  • Part 1 Epidemiology
    Chapter 1 Environmental Factors in the Epidemiology of Inflammatory Bowel Disease Morten H. Vatn
    Part 2 Immunobiology
    Chapter 2 The Intestinal Immune System in Health Per Brandtzaeg 
    Chapter 3 Understanding the Epithelial Barrier in Inflammatory Bowel Disease Matthew A. Odenwald, Jerrold R. Turner
    Chapter 4 Intestinal Microbiology and Ecology in Crohn's Disease and Ulcerative Colitis Dirk Haller, Ludovica F. Butto
    Chapter 5 The Immune System in Inflammatory Bowel Disease: Antimicrobial Peptides Charles L. Bevins
    Chapter 6 Vascular Responses to Intestinal Inflammation D. Neil Granger, Norman R. Harris
    Chapter 7  Immunobiology of Human Dendritic Cells in Inflammatory Bowel Disease Daniel C. Baumgart
    Chapter 8 Immunobiology of T-Cells in Inflammatory Bowel Disease S. Snapper, D. Nguyen, A Biswas
    Chapter 9 Immunobiology of B cells in Inflammatory Bowel Disease Atsushi Mizoguchi, Atul K. Bhan
    Chapter 10 Immune Cells: Monocytes and Macrophages Gerhard Rogler
    Chapter 11 Immune Functions of Epithelial Cells in Inflammatory Bowel Disease Eric L. Campbell, Sean P. Colgan
    Chapter 12 Autophagy and Endoplasmic Reticulum Stress Arthur Kaser
    Chapter 13 Matrix Metalloproteinases Paolo Biancheri, Thomas T. MacDonald
    Chapter 14 Paradigm of T-cell Differentiation in Inflammatory Bowel Disease Takashi Nagaishi, Mamoru Watanabe
    Chapter 15 Pharmacological Intervention Studies Using Mouse Models of Chronic Intestinal Inflammation Cynthia Reinoso Webb, Matthew B. Grisham
    Chapter 16 Stem Cells and Organoids to Study Epithelial Cell Biology in Inflammatory Bowel Disease Jorge O. Múnera, James M. Wells
    Part 3 Diagnostic Approach
    Chapter 17 Enhanced Endoscopy Ralf Kiesslich
    Chapter 18 Magnetic Resonance Enterography Patrik Rogalla, Luis Guimaraes
    Chapter 19 Computed Tomography Enterography and Inflammatory Bowel Disease J. G. Fletcher
    Chapter 20 Ultrasound in Inflammatory Bowel Disease A. Potthoff, C. Agné, M. Gebel
    Chapter 21 Laboratory Evaluation, Including Novel Diagnostic Markers M. Flamant, X. Roblin
    Chapter 22 Pathology of Inflammatory Bowel Disease Nora E. Joseph, Christopher R. Weber
    Chapter 23 Objective Assessment of Clinical Disease Activity Edouard Louis, Catherine Van Kemseke, Catherine Reenaers
    Chapter 24 Objective Assessment of Endoscopic Disease Activity and Mucosal Healing Britt Christensen, David T. Rubin
    Chapter 25 Evaluation of Quality of Life in Crohn's disease and Ulcerative Colitis: What Is Health-Related Quality of Life? Katrine Carlsen, Pia Munkholm, Johan Burisch
    Chapter 26 Evaluation of Health Economics in Inflammatory Bowel Disease Reena Khanna, Brian G. Feagan
    Part 4 Therapy Crohn’s Disease
    Chapter 27 The Natural History of Inflammatory Bowel Disease Charles N. Bernstein
    Chapter 28 Conventional Medica Management of Crohn's Disease:  Sulfasalazine Miquel A. Gassull, Eduard Cabré
    Chapter 29 Steroid Therapy for Crohn's Disease A. Hillary Steinhart
    Chapter 30 Thiopurines in Crohns' disease  Adi Lahat, Rami Eliakim
    Chapter 31 Conventional Medical Management of Crohn's Disease: Methotrexate Grace Harkin, Laurence Egan
    Chapter 32 Adalimumab for the Treatment of Crohn’s Disease  Remo Panaccione
    Chapter 33 Biologic Therapy of Crohn's Disease: Certolizumab Alessandro Armuzzi, Daniela Pugliese
    Chapter 34 Biologic Therapy of Crohn's Disease: Infliximab Jan-Michael A. Klapproth, Gary R. Lichtenstein
    Chapter 35 Briakinumab and Ustekinumab: Anti-p40 Antibodies for Inflammatory Bowel Disease Treatment Peter J. Mannon
    Chapter 36 Biologic Therapy of Crohn's Disease: Natalizumab, Vedolizumab and anti-MadCAM Pieter Hindryckx, Geert D’Haens
    Chapter 37 Optimal Management of Fistulizing Crohn's Disease Bruce Sands, Farhad Peerani
    Part 5 Therapy Ulcerative Colitis
    Chapter 38 Sulfasalazine and 5-Aminosalicylates for Ulcerative Colitis Reena Khanna, John K. Marshall 
    Chapter 39 Conventional Therapy of Ulcerative Colitis: Corticosteroids Kirstin Taylor, Peter R. Gibson
    Chapter 40 Medical Management of Ulcerative Colitis: Conventional Therapy--Azathioprine Barrett G. Levesque, Edward V. Loftus
    Chapter 41 Calcineurin Inhibitors in Ulcerative Colitis Andreas Fischer, Daniel C. Baumgart
    Chapter 42 Biologic Therapy in Moderate-to-Severe Ulcerative Colitis: Infliximab Mindy Lam, Brian Bressler
    Chapter 43 Biologic Therapy of Ulcerative Colitis: Adalimumab Walter Reinisch
    Chapter 44 Biologic Therapy of Ulcerative Colitis: Golimumab Mark A. Samaan, Peter M. Irving
    Chapter 45 Biologic Therapy of Ulcerative Colitis: Natalizumab, Vedolizumab, Etrolizumab (rHUMab beta 7), antiMadCAM Severine Vermeire 
    Chapter 46 Probiotics, Prebiotics, and Antibiotics in Inflammatory Bowel Disease Paolo Gionchetti, Carlo Calabrese, Andrea Calafiore, Fernando Rizzello
    Chapter 47 Biosimiliars in the Treatment of Inflammatory Bowel Disease Vivian W. Huang, Richard N. Fedorak
    Chapter 48 Step-up vs. Top-down Approach in Crohn’s Disease Christine Y. Yu, Daniel W. Hommes
    Chapter 49 Leucocytapheresis Therapy of Inflammatory Bowel Disease Takanori Kanai
    Chapter 50 Surgical Management of Crohn's Disease and Ulcerative Colitis Robert R. Cima, John H. Pemberton
    Part 6 Extraintestinal Manifestations 
    Chapter 51 Extraintestinal Manifestations: Autoimmune Hepatitis Michael Manns, Nora Schweitzer
    Chapter 52 Primary Sclerosing Cholangitis Roger W. Chapman, Kate D. Williamson
    Chapter 53 Autoimmune Pancreatitis and Other Organ Involvement Go Kuwata, Terumi Kamisawa
    Chapter 54 Cutaneous and Oral Manifestations of Inflammatory Bowel Disease Caroline P. Allen, Susan M. Burge 
    Chapter 55 Arthritis, Arthropathy and Osteoporosis in Inflammatory Bowel Disease Alistair Tindell, Hanna Johnsson, Iain B. McInnes
    Part 7 Nutrition
    Chapter 56 Nutrition in Inflammatory Bowel Disease Alan L. Buchman
    Part 8 Pregnancy, Family Planning and Pediatric Aspects
    Chapter 57 Pregnancy and Fertility in Inflammatory Bowel Disease Rebecca Matro, Uma Mahadevan
    Chapter 58 Pediatric Aspects of Inflammatory Bowel Disease Brendan Boyle, Jeffrey S. Hyams
    Part 9 Surveillance and Prevention
    Chapter 59 Management and Prevention of Infectious Diseases in Irritable Bowel Disease Patients Kristine Macartney, Nigel Crawford
    Chapter 60 Incidence of Cancer and Screening in Inflammatory Bowel Disease Jimmy K. Limdi, Francis A. Farraye
    Chapter 61 Inflammatory Bowel Diseases: How to Identify High Risk Patients Jacques Cosnes, Harry Sokol 
    Part 10 Patient Perspective and Resources
    Chapter 62 Patient Perspective on Inflammatory Bowel Disease Ayesha Williams, Marjorie Merrick
    Chapter 63 Patient Resources in Inflammatory Bowel Disease Sanna Lönnfors, Marco Greco